-
Sector Analysis
Industrial Fasteners Market Trends and Analysis by Region, Product (Nuts, Bolts, Screws, Studs, Rivets), End-Use and Segment Forecast to 2030
Accessing the in-depth insights from the ‘Industrial Fasteners’ report can help: Detailed market sizing based on product types, end-use sectors, and regional markets. Mapping the entire ecosystem of the value chain and stages associated with it. Detailed country-level insights with breakdown provided for key market segments. Evaluate potential growth opportunities in product and end-use segments supported by comprehensive qualitative commentary. Foresee possible changing dynamics of the sector and align business strategies to capitalize on them. List of major industrial fasteners...
-
Product Insights
NewNet Present Value Model: Bolt Biotherapeutics Inc’s Trastuzumab Imbotolimod
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Company Insights
Innovation and Patenting activity of Bolt Biotherapeutics Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Bolt Biotherapeutics Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – BOXR-1030 in Merkel Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BOXR-1030 in Merkel Cell Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BOXR-1030 in Merkel Cell Carcinoma Drug Details: BOXR-1030 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BDC-3042 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDC-3042 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BDC-3042 in Solid Tumor Drug Details: BDC-3042 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BDC-3042 in Head And Neck Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDC-3042 in Head And Neck Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BDC-3042 in Head And Neck Cancer Drug Details: BDC-3042...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BDC-3042 in Kidney Cancer (Renal Cell Cancer)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDC-3042 in Kidney Cancer (Renal Cell Cancer) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BDC-3042 in Kidney Cancer (Renal Cell Cancer) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BDC-3042 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDC-3042 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BDC-3042 in Non-Small Cell Lung Cancer Drug Details: BDC-3042...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BDC-3042 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDC-3042 in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BDC-3042 in Metastatic Colorectal Cancer Drug Details: BDC-3042 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BDC-3042 in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDC-3042 in Metastatic Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BDC-3042 in Metastatic Ovarian Cancer Drug Details: BDC-3042 is under...